🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
In recent years, diabetes has emerged as one of the most significant co-dis...
Status
Completed
Location
Children's Hospital of Philadelphia and University of Pennsylvania
Start Date
2013-06
Trial ID
NCT01879228
Treatments Being Tested
The purpose of the study is to evaluate the efficacy, safety and tolerabili...
Status
Terminated
Location
University of Connecticut Health Center
Start Date
2017-07-18
Trial ID
NCT03234465
Evaluate the efficacy, safety and tolerability of a single intraoperative d...
Status
Terminated
Location
Alabama Clinical Therapeutics, LLC
Start Date
2007-09
Trial ID
NCT00683267
Treatments Being Tested
This study is a Phase I, single-center, randomized, double-blind, placebo-c...
Status
Completed
Location
SGS clinical pharmacology unit
Start Date
2016-10-18
Trial ID
NCT03102567
This is a phase II, observer-blind, multiple-centre, randomized, placebo-co...
Status
Terminated
Location
Changhua Christian Hospital
Start Date
2021-01-30
Trial ID
NCT04773067
Motor fluctuations are identified as the most challenging symptoms by parki...
Status
Not Yet Recruiting
Location
CHU Toulouse
Start Date
2025-05-01
Trial ID
NCT06817200
Treatments Being Tested
The study proposes to evaluate the safety, tolerability, and efficacy of PD...
Status
Terminated
Location
Mount Sinai School Of Medicine/Mount Sinai Medical Center
Start Date
2013-03-15
Trial ID
NCT01732211
Treatments Being Tested
Acute kidney injury(AKI) is a common, severe emergency case in clinics,espe...
Status
Unknown
Location
Chinese PLA General Hospital
Start Date
2021-12-31
Trial ID
NCT04194671
Treatments Being Tested
Randomized, placebo-controlled, double-blind, parallel design, Phase 3 stud...
Status
Completed
Location
Warner Chilcott Investigational Site
Start Date
2009-09
Trial ID
NCT01037244
This is a randomized, double-blind, active drug- and placebo-controlled, do...
Status
Recruiting
Location
The Third Xiangya Hospital of Central South University
Start Date
2026-03-30
Trial ID
NCT07519109
Treatments Being Tested